These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37029667)

  • 1. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
    Passeri T; Gutman T; Hamza A; Adle-Biassette H; Girard E; Beaurepere R; Tariq Z; Mariani O; Dahmani A; Bourneix C; Abbritti R; Driouch K; Bohec M; Servant N; Baulande S; Decaudin D; Guichard JP; Calugaru V; Feuvret L; Guinebretière JM; Champion L; Bièche I; Froelich S; Mammar H; Masliah-Planchon J
    J Neurosurg; 2023 Nov; 139(5):1270-1280. PubMed ID: 37029667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival.
    Bai J; Shi J; Li C; Wang S; Zhang T; Hua X; Zhu B; Koka H; Wu HH; Song L; Wang D; Wang M; Zhou W; Ballew BJ; Zhu B; Hicks B; Mirabello L; Parry DM; Zhai Y; Li M; Du J; Wang J; Zhang S; Liu Q; Zhao P; Gui S; Goldstein AM; Zhang Y; Yang XR
    Nat Commun; 2021 Feb; 12(1):757. PubMed ID: 33536423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiles and clinical presentation of chordoma.
    Koka H; Zhou W; McMaster ML; Bai J; Luo W; Klein A; Zhang T; Hua X; Li X; Wang D; Xiong Y; Jones K; Vogt A; Hicks B; Parry D; Goldstein AM; Yang XR
    Acta Neuropathol Commun; 2024 Aug; 12(1):129. PubMed ID: 39135136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic aberrations frequently alter chromatin regulatory genes in chordoma.
    Wang L; Zehir A; Nafa K; Zhou N; Berger MF; Casanova J; Sadowska J; Lu C; Allis CD; Gounder M; Chandhanayingyong C; Ladanyi M; Boland PJ; Hameed M
    Genes Chromosomes Cancer; 2016 Jul; 55(7):591-600. PubMed ID: 27072194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and transcriptomic characterization of skull base chordoma.
    Sa JK; Lee IH; Hong SD; Kong DS; Nam DH
    Oncotarget; 2017 Jan; 8(1):1321-1328. PubMed ID: 27901492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in
    Passeri T; Dahmani A; Masliah-Planchon J; Naguez A; Michou M; El Botty R; Vacher S; Bouarich R; Nicolas A; Polivka M; Franck C; Schnitzler A; Némati F; Roman-Roman S; Bourdeaut F; Adle-Biassette H; Mammar H; Froelich S; Bièche I; Decaudin D
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chordoma of the skull base: predictors of tumor recurrence.
    Pallini R; Maira G; Pierconti F; Falchetti ML; Alvino E; Cimino-Reale G; Fernandez E; D'Ambrosio E; Larocca LM
    J Neurosurg; 2003 Apr; 98(4):812-22. PubMed ID: 12691407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
    Pamir MN; Ozduman K
    Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
    Huo X; Ma S; Wang C; Song L; Yao B; Zhu S; Li P; Wang L; Wu Z; Wang K
    Clin Transl Med; 2023 Oct; 13(10):e1429. PubMed ID: 37784253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chordoma].
    George B; Bresson D; Bouazza S; Froelich S; Mandonnet E; Hamdi S; Orabi M; Polivka M; Cazorla A; Adle-Biassette H; Guichard JP; Duet M; Gayat E; Vallée F; Canova CH; Riet F; Bolle S; Calugaru V; Dendale R; Mazeron JJ; Feuvret L; Boissier E; Vignot S; Puget S; Sainte-Rose C; Beccaria K
    Neurochirurgie; 2014 Jun; 60(3):63-140. PubMed ID: 24856008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of a Category Based on Electron Microscopic Features of Clival Chordomas.
    Bai J; Zhai Y; Wang S; Gao H; Du J; Wang J; Li M; Li C; Gui S; Zhang C; Sun Y; Zhang Y
    World Neurosurg; 2017 Mar; 99():282-287. PubMed ID: 27916725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Implications of Gadolinium Enhancement of Skull Base Chordomas.
    Lin E; Scognamiglio T; Zhao Y; Schwartz TH; Phillips CD
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1509-1514. PubMed ID: 29903925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-Based Optimization of Post-Treatment Surveillance for Skull Base Chordomas Based on Local and Distant Disease Progression.
    Freeman JL; Kaufmann AB; Everson RG; DeMonte F; Raza SM
    Oper Neurosurg (Hagerstown); 2019 Jan; 16(1):27-36. PubMed ID: 29912434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival.
    Vuong HG; Dunn IF
    World Neurosurg; 2022 Jun; 162():e635-e639. PubMed ID: 35339711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival.
    Ye S; Zhou S; Wu Y; Pei X; Jiang W; Shi W; Yang W; Zhou X; Shan B; Yang H
    Ann Med; 2023 Dec; 55(1):2218104. PubMed ID: 37272300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Therapeutic Targets in Chordomas: A Review of the Literature in the Genomic Era.
    Gill CM; Fowkes M; Shrivastava RK
    Neurosurgery; 2020 Feb; 86(2):E118-E123. PubMed ID: 31504814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of histopathological parameters, genome-wide copy number alterations, and variants in genes involved in cell cycle regulation in chordomas of the skull base and sacrum.
    Salle H; Durand S; Durand K; Bourthoumieu S; Lemnos L; Robert S; Pollet J; Passeri T; Khalil W; Froelich S; Adle-Biassette H; Labrousse F
    J Neuropathol Exp Neurol; 2023 Mar; 82(4):312-323. PubMed ID: 36779322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-Cbl and Cbl-b expression in skull base chordomas is associated with tumor progression and poor prognosis.
    Luo P; Wang X; Zhou J; Li L; Jing Z
    Hum Pathol; 2018 Apr; 74():129-134. PubMed ID: 29317233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal column chordoma: prognostic significance of clinical variables and T (brachyury) gene SNP rs2305089 for local recurrence and overall survival.
    Bettegowda C; Yip S; Lo SL; Fisher CG; Boriani S; Rhines LD; Wang JY; Lazary A; Gambarotti M; Wang WL; Luzzati A; Dekutoski MB; Bilsky MH; Chou D; Fehlings MG; McCarthy EF; Quraishi NA; Reynolds JJ; Sciubba DM; Williams RP; Wolinsky JP; Zadnik PL; Zhang M; Germscheid NM; Kalampoki V; Varga PP; Gokaslan ZL;
    Neuro Oncol; 2017 Mar; 19(3):405-413. PubMed ID: 27663388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical Management of Skull Base and Spine Chordomas.
    Passer JZ; Alvarez-Breckenridge C; Rhines L; DeMonte F; Tatsui C; Raza SM
    Curr Treat Options Oncol; 2021 Mar; 22(5):40. PubMed ID: 33743089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.